<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Depression Research: Neurobiological & Diagnostic Approaches</title>
  <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@400;700&family=Raleway:wght@300;500&display=swap" rel="stylesheet">
  <style>
    * {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: 'Raleway', sans-serif;
      line-height: 1.8;
      background: #f5f5f5;
      color: #333;
      overflow-x: hidden;
      font-size: 18px;
      background-image: linear-gradient(135deg, #f5f7fa 0%, #e4e8f0 100%);
    }

    .container {
      max-width: 1200px;
      margin: 0 auto;
      padding: 40px 20px;
      background-color: white;
      box-shadow: 0 0 30px rgba(0,0,0,0.1);
      border-radius: 5px;
      position: relative;
      overflow: hidden;
    }

    h1 {
      font-family: 'Playfair Display', serif;
      font-size: 3rem;
      color: #2c3e50;
      text-align: center;
      margin: 40px 0;
      padding-bottom: 20px;
      border-bottom: 2px solid #e74c3c;
      position: relative;
    }

    h1:after {
      content: "";
      position: absolute;
      bottom: -5px;
      left: 50%;
      transform: translateX(-50%);
      width: 100px;
      height: 3px;
      background: #3498db;
    }

    h2 {
      font-family: 'Playfair Display', serif;
      font-size: 2.2rem;
      color: #2c3e50;
      margin: 40px 0 20px;
      padding-bottom: 10px;
      border-bottom: 1px solid #eee;
    }

    h3 {
      font-family: 'Playfair Display', serif;
      font-size: 1.8rem;
      color: #2c3e50;
      margin: 30px 0 15px;
    }

    h4 {
      font-family: 'Playfair Display', serif;
      font-size: 1.4rem;
      color: #2c3e50;
      margin: 25px 0 15px;
    }

    .article-section {
      display: flex;
      flex-wrap: wrap;
      gap: 40px;
      margin-bottom: 60px;
      align-items: flex-start;
    }

    .article-section:nth-child(even) {
      flex-direction: row-reverse;
    }

    .text {
      flex: 2;
      min-width: 300px;
      padding: 20px;
    }

    p {
      margin-bottom: 25px;
      color: #555;
      font-size: 1.1rem;
      text-align: justify;
    }

    ul, ol {
      margin-left: 40px;
      margin-bottom: 25px;
    }

    li {
      margin-bottom: 10px;
      color: #555;
    }

    .abstract {
      background-color: #f8f9fa;
      padding: 25px;
      border-radius: 8px;
      margin-bottom: 40px;
      border-left: 5px solid #3498db;
    }

    .abstract h2 {
      margin-top: 0;
      color: #3498db;
    }

    .author {
      margin-top: 60px;
      font-weight: 600;
      text-align: right;
      color: #2c3e50;
      font-size: 1.2rem;
      font-style: italic;
      padding-top: 20px;
      border-top: 1px solid #eee;
    }

    .caption {
      text-align: center;
      margin-top: 10px;
      color: #7f8c8d;
      font-size: 0.9rem;
      font-style: italic;
    }

    /* استبدال image-placeholder بـ image-container */
    .image-container {
      flex: 1;
      min-width: 300px;
      max-width: 500px;
      border-radius: 8px;
      overflow: hidden;
      transition: all 0.5s ease;
      opacity: 0;
      transform: translateY(30px);
      box-shadow: 0 5px 15px rgba(0,0,0,0.1);
    }

    .image-container.visible {
      opacity: 1;
      transform: translateY(0);
    }

    .image-container:hover {
      transform: scale(1.02) translateY(-5px);
      box-shadow: 0 15px 40px rgba(0,0,0,0.3);
    }

    .image-container img {
      width: 100%;
      height: 300px;
      object-fit: cover;
      display: block;
    }

    .research-highlights {
      background-color: #e8f4f8;
      padding: 25px;
      border-radius: 8px;
      margin: 30px 0;
      border-left: 5px solid #2c3e50;
    }

    .research-highlights h3 {
      color: #2c3e50;
      margin-top: 0;
    }

    .treatment-section {
      background-color: #f0f8f0;
      padding: 25px;
      border-radius: 8px;
      margin: 30px 0;
      border-left: 5px solid #27ae60;
    }

    .treatment-section h3 {
      color: #27ae60;
      margin-top: 0;
    }

    .symptoms-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
      gap: 20px;
      margin: 25px 0;
    }

    .symptom-category {
      background: #f8f9fa;
      padding: 20px;
      border-radius: 8px;
      border-left: 4px solid #e74c3c;
    }

    .symptom-category h4 {
      margin-top: 0;
      color: #e74c3c;
    }

    @media(max-width: 768px) {
      .article-section, 
      .article-section:nth-child(even) {
        flex-direction: column;
      }
      
      .image-container {
        max-width: 100%;
      }
      
      h1 {
        font-size: 2.2rem;
      }
      
      h2 {
        font-size: 1.8rem;
      }
      
      .symptoms-grid {
        grid-template-columns: 1fr;
      }
    }

    /* Floating image effect */
    @keyframes float {
      0% { transform: translateY(0px); }
      50% { transform: translateY(-10px); }
      100% { transform: translateY(0px); }
    }

    .floating-img {
      animation: float 6s ease-in-out infinite;
    }

    .specifier-list {
      columns: 2;
      column-gap: 40px;
    }

    .specifier-list li {
      break-inside: avoid;
    }

    @media(max-width: 768px) {
      .specifier-list {
        columns: 1;
      }
    }
  </style>
</head>
<body>

  <div class="container">
    <h1>Depression: Neurobiological Research & Diagnostic Approaches</h1>

    <div class="abstract">
      <h2>Abstract</h2>
      <p>Current diagnosis and treatment in psychiatry rely heavily on patient reports and physician judgments and are therefore sensitive to memory biases and subjectivity. On the other hand, increased efforts to develop objective indicators in psychiatry may be a way to address all these challenges.</p>
      <p>Vocal acoustic features have recently been studied as objective measures, given their accessibility, low cost, non-invasiveness, and remote access.</p>
      <p>The main objective of this work is to propose a methodology to support the diagnosis of major depressive disorder, bipolar disorder, schizophrenia, anxiety disorders, social phobia, autism, obsessive-compulsive disorder, and hyperactivity using acoustic analysis and machine learning. Seventy-eight individuals over the age of eighteen were recruited into five groups: 28 participants with major depressive disorder; 20 patients with schizophrenia; 15 patients with bipolar disorder; 4 patients with generalized anxiety disorder; and 12 healthy controls. Since changes in voice patterns have been reported in several psychiatric disorders and appear to correlate with disease severity, acoustic features have proven to be promising indicators due to their availability, low cost, non-invasiveness, and remote access. The results of our proposed solution support the feasibility of using a computational method based on acoustic parameters to assist clinicians in triaging and diagnosing patients in psychiatric settings.</p>
    </div>

    <h2>Introduction</h2>

    <div class="article-section">
      <div class="text">
        <h3>Understanding Depression</h3>
        <p>Depression is a mood disorder that may lead to severe outcomes including mental breakdown, self-injury, and suicide. Potential causes of depression include genetic, sociocultural, and individual-level factors. However, public understandings of depression guided by a complex interplay of media and other societal discourses might not be congruent with the scientific knowledge. Misunderstandings of depression can lead to under-treatment and stigmatization of depression.</p>
        <p>It is a common yet severe mood disorder with holistic impact on individuals including their mood, perceptions, cognitions, and daily activities such as sleeping, food intake, working, etc, affecting more than 300 million people worldwide. Despite the increasing prevalence of depression, compared to other countries, the rate of diagnosed depression is relatively low, suggesting a collective denial and under treatment of depression as a disease.</p>
        <p>Depression is a mental health disorder characterized by persistent feelings of sadness or loss of interest or pleasure in activities that a person once enjoyed, as well as significant impact on thinking, behavior, and daily functioning. According to the World Health Organization (WHO), depression "is different from normal mood changes and is a common disorder that can affect all aspects of life. A medical source such as the Mayo Clinic explains that depression is a mood disorder that causes persistent feelings of sadness or loss of interest and can interfere with your daily life.</p>
      </div>
      <div>
        <div class="image-container floating-img">
          <img src="1dep.jpg" alt="Brain Activity in Depression">
        </div>
        <div class="caption">Figure 1: Neural correlates of depression showing altered brain activity patterns</div>
      </div>
    </div>

    <div class="article-section">
      <div>
        <div class="image-container floating-img">
          <img src="2dep.jpg" alt="Depression Comorbidities">
        </div>
        <div class="caption">Figure 2: Depression association with chronic physical conditions</div>
      </div>
      <div class="text">
        <h3>Depression and Physical Health</h3>
        <p>It shows a strong association with numerous chronic physical conditions, including diabetes, arthritis, multiple sclerosis, congestive heart failure, hypertension, coronary artery disease, chronic obstructive pulmonary disease and end-stage renal disease. There are further associations with non-specific syndromes such as obesity, the coexistence of depression and chronic physical conditions that predict significantly worsening health status. It is considered by some to be a modifiable risk factor for morbidity and mortality in conditions such as diabetes and cardiovascular disease. In addition, suicide may be relatively more common among those with certain chronic physical illnesses. Individuals with depression are three times less likely to adhere to medical treatment than individuals without depression.</p>
        <p>Effective treatment of depression might therefore be expected to improve functional disability and health-related quality of life for people with depression and chronic physical health problems. Even if these predicted benefits are discounted, the effective treatment of depression in chronic physical illness can be considered no less desirable than the effective treatment of depression in the absence of physical health problems. In the clinical care of this population, however, depression is often not recognized and diagnosed. When it is recognized, some clinicians may be reluctant to prescribe antidepressants in physical illness because of concerns about adverse physical effects or drug interactions.</p>
      </div>
    </div>

    <h2>Symptoms of Depression</h2>

    <div class="article-section">
      <div class="text">
        <p>The symptoms of depression can be complex and vary widely between people. If you're depressed, you may feel sad, hopeless and lose interest in things you used to enjoy. The symptoms persist for weeks or months and are bad enough to interfere with your work, social life and family life.</p>
        <p>Although depression may occur only once during your life, people typically have multiple episodes. During these episodes, symptoms occur most of the day, nearly every day and may include causing feelings of sadness, tearfulness, emptiness, or hopelessness. It may also lead to angry outbursts, irritability, or frustration, even over small matters. People experiencing depression often lose interest or pleasure in most or all normal activities, such as sex, hobbies, or sports. Sleep disturbances are common, including insomnia or sleeping too much. Individuals may feel tired and lack energy, so even small tasks take extra effort. Appetite changes can occur as well, leading to reduced appetite and weight loss or increased cravings for food and weight gain. Depression may also cause anxiety, agitation, or restlessness. It can slow down thinking, speaking, or body movements. Many people experience feelings of worthlessness or guilt, often fixating on past failures or engaging in self-blame. Trouble thinking, concentrating, making decisions, and remembering things is also frequent. In more severe cases, depression can lead to frequent or recurrent thoughts of death, suicidal thoughts, suicide attempts, or suicide. Additionally, individuals may suffer from unexplained physical problems, such as back pain or headaches.</p>
      </div>
      <div>
        <div class="image-container floating-img">
          <img src="3dep.jpg" alt="Depression Symptoms Spectrum">
        </div>
        <div class="caption">Figure 3: The multifaceted symptoms of depression across emotional, cognitive, and physical domains</div>
      </div>
    </div>

    <div class="symptoms-grid">
      <div class="symptom-category">
        <h4>Psychological Symptoms</h4>
        <ul>
          <li>Continuous low mood or sadness</li>
          <li>Feeling hopeless and helpless</li>
          <li>Having low self-esteem</li>
          <li>Feeling tearful</li>
          <li>Feeling guilt-ridden</li>
          <li>Feeling irritable and intolerant of others</li>
          <li>Having no motivation or interest in things</li>
          <li>Finding it difficult to make decisions</li>
          <li>Not getting any enjoyment out of life</li>
          <li>Feeling anxious or worried</li>
          <li>Having suicidal thoughts or thoughts of harming yourself</li>
        </ul>
      </div>
      
      <div class="symptom-category">
        <h4>Physical Symptoms</h4>
        <ul>
          <li>Moving or speaking more slowly than usual</li>
          <li>Changes in appetite or weight (usually decreased, but sometimes increased)</li>
          <li>Constipation</li>
          <li>Unexplained aches and pains</li>
          <li>Lack of energy</li>
          <li>Low sex drive (loss of libido)</li>
          <li>Disturbed sleep – difficulty falling asleep or waking up very early</li>
        </ul>
      </div>
      
      <div class="symptom-category">
        <h4>Social Symptoms</h4>
        <ul>
          <li>Avoiding contact with friends</li>
          <li>Taking part in fewer social activities</li>
          <li>Neglecting hobbies and interests</li>
          <li>Having difficulties in home, work or family life</li>
        </ul>
      </div>
    </div>

    <h3>Depression Across the Lifespan</h3>
    
    <div class="article-section">
      <div>
        <div class="image-container floating-img">
          <img src="4dep.jpg" alt="Depression Across Lifespan">
        </div>
        <div class="caption">Figure 4: Manifestation of depression symptoms across different age groups</div>
      </div>
      <div class="text">
        <h4>Children and Teens</h4>
        <p><strong>Younger children:</strong> Symptoms may include sadness, irritability, clinginess, worry, aches and pains, refusing to go to school, or being underweight.</p>
        <p><strong>Teens:</strong> Symptoms may include sadness, irritability, feeling negative and worthless, anger, poor performance or poor attendance at school, feeling misunderstood and extremely sensitive, using recreational drugs or alcohol, eating or sleeping too much, self-harm, loss of interest in normal activities, and avoidance of social interaction.</p>
        
        <h4>Older Adults</h4>
        <p>Depression is not a normal part of growing older, and it should never be taken lightly. Unfortunately, depression often goes undiagnosed and untreated in older adults, and they may feel reluctant to seek help.</p>
      </div>
    </div>

    <h3>Depression Specifiers</h3>
    <p>Symptoms caused by major depression can vary from person to person. To clarify the type of depression you have, your doctor may add one or more specifiers. A specifier means that you have depression with specific features, such as:</p>
    
    <ul class="specifier-list">
      <li><strong>Anxious distress:</strong> depression with unusual restlessness or worry about possible events or loss of control</li>
      <li><strong>Mixed features:</strong> simultaneous depression and mania, which includes elevated self-esteem, talking too much and increased energy</li>
      <li><strong>Melancholic features:</strong> severe depression with lack of response to something that used to bring pleasure and is associated with early morning awakening, worsened mood in the morning, major changes in appetite, and feelings of guilt, agitation or sluggishness</li>
      <li><strong>Atypical features:</strong> depression that includes the ability to temporarily be cheered by happy events, increased appetite, excessive need for sleep, sensitivity to rejection, and a heavy feeling in the arms or legs</li>
      <li><strong>Psychotic features:</strong> depression accompanied by delusions or hallucinations, which may involve personal inadequacy or other negative themes</li>
      <li><strong>Catatonia:</strong> depression that includes motor activity that involves either uncontrollable and purposeless movement or fixed and inflexible posture</li>
      <li><strong>Peripartum onset:</strong> depression that occurs during pregnancy or in the weeks or months after delivery (postpartum)</li>
      <li><strong>Seasonal pattern:</strong> depression related to changes in seasons and reduced exposure to sunlight</li>
    </ul>

    <h2>Types of Depression</h2>

    <div class="article-section">
      <div class="text">
        <p>There are different types of depression, and some conditions where depression may be one of the symptoms. These include postnatal depression, bipolar disorder, seasonal affective disorder (SAD), and premenstrual dysphoric disorder (PMDD). Each type has distinct characteristics, causes, and patterns, but all share the common feature of persistent low mood and loss of interest or pleasure in daily life.</p>
        
        <h3>Major Depressive Disorder (MDD) or Clinical depression</h3>
        <p>Depression ranges in seriousness from mild, temporary episodes of sadness to severe, persistent depression. Clinical depression is the more severe form of depression, also known as major depression or major depressive disorder. It isn't the same as depression caused by a loss, such as the death of a loved one, or a medical condition, such as a thyroid disorder.</p>
        <p>To diagnose clinical depression, many doctors use the symptom criteria for major depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association. Signs and symptoms of clinical depression may include:</p>
        <ul>
          <li>Feelings of sadness, tearfulness, emptiness or hopelessness</li>
          <li>Angry outbursts, irritability or frustration, even over small matters</li>
          <li>Loss of interest or pleasure in most or all normal activities, such as sex, hobbies or sports</li>
          <li>Sleep disturbances, including insomnia or sleeping too much</li>
          <li>Tiredness and lack of energy, so even small tasks take extra effort</li>
          <li>Reduced appetite and weight loss or increased cravings for food and weight gain</li>
          <li>Anxiety, agitation or restlessness</li>
          <li>Slowed thinking, speaking or body movements</li>
          <li>Feelings of worthlessness or guilt, fixating on past failures or self-blame</li>
          <li>Trouble thinking, concentrating, making decisions and remembering things</li>
          <li>Frequent or recurrent thoughts of death, suicidal thoughts, suicide attempts or suicide</li>
          <li>Unexplained physical problems, such as back pain or headaches</li>
        </ul>
        <p>Symptoms are usually severe enough to cause noticeable problems in relationships with others or in day-to-day activities, such as work, school or social activities.</p>
        <p>Clinical depression can affect people of any age, including children. However, clinical depression symptoms, even if severe, usually improve with psychological counseling, antidepressant medications or a combination of the two.</p>
      </div>
      <div>
        

    <h3>Other Types of Depression</h3>
    
    <div class="article-section">
      
      <div class="text">
        <h4>Persistent Depressive Disorder (PDD)</h4>
        <p>Formerly known as dysthymia, is a chronic form of depression where symptoms are less intense than in major depression but last for a much longer period, typically two years or more in adults. People with PDD often feel generally unhappy or "down," even if they can manage their daily responsibilities. This long-term pattern can lead to significant impairment in quality of life, despite the relatively milder symptoms. Symptoms of psychotic depression can include hallucinations, delusions and paranoia. This is a less severe but more chronic form of depression. While it's usually not disabling, persistent depressive disorder can prevent you from functioning normally in your daily routine and from living life to its fullest.</p>
        
        <h4>Seasonal Affective Disorder (SAD)</h4>
        <p>It follows a seasonal pattern, most often appearing during the winter months when daylight hours are shorter. Individuals with SAD may experience low mood, increased sleep, overeating (especially cravings for carbohydrates), and reduced energy. Symptoms usually improve with the return of longer daylight hours in spring and summer. The condition is believed to be linked to changes in light exposure, which can affect the body's internal clock and serotonin levels.</p>
        
        <h4>Postnatal Depression</h4>
        <p>It occurs after childbirth and can affect new mothers, fathers, or partners. It is more than just the "baby blues," which are temporary mood swings that typically resolve within a few days. Postnatal depression involves prolonged feelings of sadness, anxiety, fatigue, and difficulty bonding with the baby. It can interfere with the ability to care for oneself or the infant and often requires treatment through therapy and, in some cases, medication.</p>
        
        <h4>Psychotic Depression</h4>
        <p>It is a severe form of depression accompanied by symptoms of psychosis, such as hallucinations (seeing or hearing things that are not real) or delusions (strongly held false beliefs). Individuals may believe they are guilty of terrible things, being watched, or that something catastrophic is about to happen. This form of depression requires urgent and specialized treatment, usually combining antidepressant and antipsychotic medications.</p>
        
        <h4>Premenstrual Dysphoric Disorder (PMDD)</h4>
        <p>It is a severe form of premenstrual syndrome (PMS) characterized by intense emotional and physical symptoms in the weeks before menstruation. Women with PMDD experience severe mood swings, depression, anxiety, irritability, and difficulty concentrating. These symptoms usually resolve once menstruation begins. PMDD is thought to be related to hormonal fluctuations that affect mood-regulating chemicals in the brain.</p>
      </div>
    </div>

    <h3>Other Related Depressive Disorders</h3>
    <p>Other forms of depression can occur in connection with specific medical or environmental factors. For instance, depression may develop because of medical conditions such as thyroid disease, chronic pain, or neurological disorders. Substance- or medication-induced depression can also occur when drugs or alcohol alter brain chemistry. Identifying the underlying cause is essential for effective treatment and recovery.</p>
    <p>Each of these types of depression shares similar emotional challenges but differs in duration, triggers, and severity. Accurate diagnosis by a mental health professional is crucial for determining the most appropriate treatment plan.</p>

    <h2>Diagnosis</h2>
    
    <div class="article-section">
      <div class="text">
        <p>Diagnosis of depression typically involves several approaches:</p>
        <ul>
          <li><strong>Physical exam:</strong> By asking questions about your health. In some cases, depression may be linked to an underlying physical health problem.</li>
          <li><strong>Lab tests:</strong> For example, your doctor may do a blood test called a complete blood count or test your thyroid to make sure it's functioning properly.</li>
          <li><strong>Psychiatric evaluation:</strong> Your mental health professional asks about your symptoms, thoughts, feelings and behavior patterns. You may be asked to fill out a questionnaire to help answer these questions.</li>
          <li><strong>DSM-5:</strong> Your mental health professional may use the criteria for depression listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association.</li>
        </ul>
      </div>
      <div>

    <h2>Treatment</h2>
    
    <div class="treatment-section">
      <h3>Treatment Overview</h3>
      <p>Medications and psychotherapy are effective for most people with depression. Your primary care doctor or psychiatrist can prescribe medications to relieve symptoms. However, many people with depression also benefit from seeing a psychiatrist, psychologist or other mental health professionals. If you have severe depression, you may need a hospital stay, or you may need to participate in an outpatient treatment program until your symptoms improve.</p>
    </div>

    <h3>Medications</h3>
    
    <div class="article-section">
      <div class="text">
        <p>Many types of antidepressants are available, including those below. Be sure to discuss possible major side effects with your doctor or pharmacist.</p>
        
        <h4>Selective serotonin reuptake inhibitors (SSRIs)</h4>
        <p>Doctors often start by prescribing SSRI, These drugs are considered safer and generally cause fewer bothersome side effects than other types of antidepressants. SSRIs include citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil, Pexeva), sertraline (Zoloft) and vilazodone (Viibryd).</p>
        
        <h4>Serotonin-norepinephrine reuptake inhibitors (SNRIs)</h4>
        <p>Examples of SNRIs include duloxetine (Cymbalta), venlafaxine (Effexor XR), desvenlafaxine (Pristiq, Khedezla) and levomilnacipran (Fetzima).</p>
        
        <h4>Atypical antidepressants</h4>
        <p>These medications don't fit neatly into any of the other antidepressant categories. They include bupropion (Wellbutrin XL, Wellbutrin SR, Aplenzin, Forfivo XL), mirtazapine (Remeron), nefazodone, trazodone and vortioxetine (Trintellix).</p>
        
        <h4>Tricyclic antidepressants</h4>
        <p>These drugs such as imipramine (Tofranil), nortriptyline (Pamelor), amitriptyline, doxepin, trimipramine (Surmontil), desipramine (Norpramin) and protriptyline (Vivactil) can be very effective, but tend to cause more-severe side effects than newer antidepressants. So tricyclics generally aren't prescribed unless you've tried an SSRI first without improvement.</p>
        
        <h4>Monoamine oxidase inhibitors (MAOIs)</h4>
        <p>such as tranylcypromine (Parnate), phenelzine (Nardil) and isocarboxazid (Marplan) may be prescribed, typically when other drugs haven't worked, because they can have serious side effects. Using MAOIs requires a strict diet because of dangerous (or even deadly) interactions with foods such as certain cheeses, pickles and wines and some medications and herbal supplements. Selegiline (Emsam), a newer MAOI that sticks to the skin as a patch, may cause fewer side effects than other MAOIs do. These medications can't be combined with SSRIs.</p>
        
        <h4>Other medications</h4>
        <p>Other medications may be added to an antidepressant to enhance antidepressant effects. Your doctor may recommend combining two antidepressants or adding medications such as mood stabilizers or antipsychotics. Anti-anxiety and stimulant medications also may be added for short-term use.</p>
      </div>
      <div>
        <div class="image-container floating-img">
          <img src="5dep.jpg" alt="Antidepressant Medications">
        </div>
        <div class="caption">Figure 5: Different classes of antidepressant medications and their mechanisms</div>
      </div>
    </div>

    <h3>Finding the Right Medication</h3>
    <p>If a family member has responded well to an antidepressant, it may be one that could help you. Or you may need to try several medications or a combination of medications before you find one that works. This requires patience, as some medications need several weeks or longer to have full effect and for side effects to ease as your body adjusts.</p>
    <p>Inherited traits play a role in how antidepressants affect you. In some cases, where available, results of genetic tests (done by a blood test or cheek swab) may offer clues about how your body may respond to a particular antidepressant. However, other variables besides genetics can affect your response to medication.</p>

    <h3>Risks and Considerations</h3>
    <p><strong>Risks of abruptly stopping medication:</strong> Don't stop taking an antidepressant without talking to your doctor first. Antidepressants aren't considered addictive, but sometimes physical dependence (which is different from addiction) can occur. Stopping treatment abruptly or missing several doses can cause withdrawal-like symptoms, and quitting suddenly may cause a sudden worsening of depression. Work with your doctor to gradually and safely decrease your dose.</p>
    <p><strong>Antidepressants and pregnancy:</strong> If you're pregnant or breast-feeding, some antidepressants may pose an increased health risk to your unborn child or nursing child. Talk to your doctor to see if you become pregnant or you're planning to become pregnant.</p>
    <p><strong>Antidepressants and increased suicide risk:</strong> Most antidepressants are generally safe, but the Food and Drug Administration (FDA) requires all antidepressants to carry a black box warning, the strictest warning for prescriptions. In some cases, children, teenagers and young adults under age 25 may have an increase in suicidal thoughts or behavior when taking antidepressants, especially in the first few weeks after starting or when the dose is changed. Anyone taking an antidepressant should be watched closely for worsening depression or unusual behavior, especially when starting a new medication or with a change in dosage. If you or someone you know has suicidal thoughts when taking an antidepressant, immediately contact a doctor or get emergency help. Keep in mind that antidepressants are more likely to reduce suicide risk in the long run by improving mood.</p>

    <h3>Psychotherapy</h3>
    <p>Psychotherapy is a general term for treating depression by talking about your condition and related issues with a mental health professional. Psychotherapy is also known as talk therapy or psychological therapy.</p>
    <p>Different types of psychotherapy can be effective for depression, such as cognitive behavioral therapy or interpersonal therapy. Your mental health professional may also recommend other types of therapies. Psychotherapy can help you:</p>
    <ul>
      <li>Adjust to a crisis or other current difficulty</li>
      <li>Identify negative beliefs and behaviors and replace them with healthy, positive ones</li>
      <li>Explore relationships and experiences, and develop positive interactions with others</li>
      <li>Find better ways to cope and solve problems</li>
      <li>Identify issues that contribute to your depression and change behaviors that make it worse</li>
      <li>Regain a sense of satisfaction and control in your life and help ease depression symptoms, such as hopelessness and anger</li>
      <li>Learn to set realistic goals for your life</li>
      <li>Develop the ability to tolerate and accept distress using healthier behaviors</li>
    </ul>

    <h3>Other Treatment Options</h3>
    
    <div class="article-section">
      <div class="text">
        <h4>Hospital and Residential Treatment</h4>
        <p>In some people, depression is so severe that a hospital stay is needed. This may be necessary if you can't care for yourself properly or when you're in immediate danger of harming yourself or someone else. Psychiatric treatment at a hospital can help keep you calm and safe until your mood improves. Partial hospitalization or day treatment programs also may help some people. These programs provide outpatient support and counseling needed to get symptoms under control.</p>
        
        <h4>Electroconvulsive Therapy (ECT)</h4>
        <p>In ECT, electrical currents are passed through the brain to impact the function and effect of neurotransmitters in your brain to relieve depression. ECT is usually used for people who don't get better with medications, can't take antidepressants for health reasons or are at high risk of suicide.</p>
        
        <h4>Transcranial Magnetic Stimulation (TMS)</h4>
        <p>TMS may be an option for those who haven't responded to antidepressants. During TMS, a treatment coil placed against your scalp sends brief magnetic pulses to stimulate nerve cells in your brain that are involved in mood regulation and depression.</p>
      </div>
      <div>

    <h2>Neurobiological Research</h2>

    <div class="research-highlights">
      <h3>fMRI Studies on Depression</h3>
      <p>Using functional magnetic resonance imaging (fMRI) to compare healthy controls (HC) and patients with depression (MDD), we used light network analysis, specifically the Salient Network (SAL), which was reduced to the Brazilian social selection.</p>
      <p>(A) SAL in healthy controls: Illustrating the areas of SAL network activity in healthy individuals. The black shaded area in the brain (LPFC, AI, ACC) represents the activity. The percentage (3.17% of the cortex) means that the network covers approximately 3% of the cerebral cortex in healthy individuals.</p>
      <p>Regional areas: LPFC: lateral prefrontal lobe (control and attention), AI: insular (sensation of physical and emotional states), and ACC: stenographic hat (different deregulation).</p>
    </div>

    <div class="article-section">
      <div>
        <div class="image-container floating-img">
          <img src="6dep.jpg" alt="SAL Network Activity">
        </div>
        <div class="caption">Figure 6: Salience Network (SAL) activity in healthy controls vs. depressed patients</div>
      </div>
      <div class="text">
        <p>(b) SIMD-1 / SIMD-2 / SIMD-4: These illustrate different types (subtypes) of depression, called SIMD. Each subtype has a different distribution of the SAL network in the brain, with a higher percentage than healthy controls (5.7%, 4.6%, 5.2%). This means that activity in the network is 99% higher in depression indicators compared to healthy controls → this indicates impaired regulation of emotions and attention.</p>
        <p>(c) Graphs comparing the percentage of SAL network opt-outs between: HC (healthy controls) & SMD or MDD (patients) Significantly higher in patients with activity, structural and functional differences were found in the network.</p>
        <p>(d) Same concept, but measuring activity in the striatum (a brain region involved in reward and motivation). There is not a significant difference, but the overall error indicates increased depression.</p>
        <p>(e) SAL Density Maps: These color maps illustrate the network makeup in each brain region: In healthy individuals: activity is limited and concentrated. In depression: activity is widespread and more prevalent in emotional and affective areas. The colors illustrate the proportions of people with activity in each region (darker color = more activity).</p>
      </div>
    </div>

    <div class="research-highlights">
      <h3>Machine Learning Applications</h3>
      <p>(f) A learning machine model (SVM): used fMRI data to differentiate between healthy and depressed individuals. Accuracy rate = 78.4%. The table in English is the confusion matrix: The model correctly predicted healthy individuals 62.1% of the time. The analysis predicted depressed individuals 82.5% of the time.</p>
      <p>(z) Weights Advantage: This figure illustrates the most significant gains that contributed to the category, which were from the SAL network more than other networks. This means that the SAL network is the strongest predictor of depression.</p>
      <p>(h) Loss of Accuracy: The experience here is: If we remove a specific network from the analysis, is the accuracy confirmed? When they removed SAL, the scientists clearly demonstrated the accuracy, proving it was the most important network for training between healthy and depressed individuals.</p>
      <p>The SAL network (salience network) is more active and expanded in patients with depression. This network is required as a biomarker for early diagnosis. Artificial intelligence discovers the precise truth by analyzing the activity of this neural network.</p>
    </div>

    <h2>Gut Microbiome Research</h2>

    <div class="article-section">
      <div class="text">
        <p>Another study comparing healthy individuals (HC) and a group of patients with chronic depression (MDD) at the gut microbiome/metabolite level (bacterial taxa, metabolites/short-chain fatty acids, and a potential inflammatory pattern) was conducted. The goal was to demonstrate differences in diversity, dominant species, and associations between bacteria and biochemicals associated with disease states.</p>
        
        <p>(A) Alpha Diversity Comparisons and Boxplots: This panel displays a set of boxplots representing indices of internal diversity of the microbial community (alpha diversity), such as Chao1 and Observed OTUs (for species richness), Faith's Phylogenetic Diversity (PD) (for phylogenetic dimension), Shannon Index (for diversity measurement), and Pielou's Evenness (for homogeneity). The values for each group are displayed as dots, with the blue dots representing the healthy individual (HC) group and the red dots representing the MDD group. Above each plot is the p-value resulting from the statistical test used to compare the two groups. Some measures indicated statistically significant differences (e.g., p = 0.018, p = 0.031, p = 0.0072), while others showed no significant differences (p ≈ 0.9 or p = 0.6). These results demonstrate that some indicators of microbial diversity, including richness, phylogenetic dimension, and overall diversity, differ significantly between healthy and depressed individuals, suggesting that depression may be associated with alterations in the balance and diversity of the human microbiome.</p>
      </div>
      <div>
        <div class="image-container floating-img">
          <img src="7dep.jpg" alt="Gut Microbiome Analysis">
        </div>
        <div class="caption">Figure 7: Alpha diversity comparisons between healthy controls and depressed patients</div>
      </div>
    </div>

    <div class="article-section">
      <div>
        <div class="image-container floating-img">
          <img src="8dep.jpg" alt="Beta Diversity Analysis">
        </div>
        <div class="caption">Figure 8: Beta diversity analysis showing compositional differences</div>
      </div>
      <div class="text">
        <p>(B) Beta Diversity / Distance to HC: This figure shows box plots representing the distances between each sample and the reference center of the healthy control group (HC), using metrics such as Bray–Curtis or UniFrac. The blue column represents the distance between the healthy samples themselves, while the red column represents the distances between the depressed samples and the healthy control samples. The results indicate that the microbial community composition of individuals with depression differs significantly from that of healthy individuals, reflecting a significant compositional change (beta diversity) between the two groups.</p>
        
        <p>(C) LDA/LEfSe analysis to identify distinct taxa (Bar Chart): This figure shows the results from a Linear Discriminant Analysis Effect Size (LEfSe) analysis used to identify the most discriminating taxa (genera or families) between the two groups. The blue bars represent the most abundant taxa in the health control group (HC), while the red bars indicate the most abundant taxa in the MDD group. The length of each bar indicates the LDA score, which reflects the statistical effect size of each taxa in distinguishing the two groups. The results demonstrate the presence of a bacterial population associated with healthy individuals, often associated with beneficial microbial functions, versus more abundant bacterial species in depressed individuals, which may be related to inflammatory environments or metabolic disorders.</p>
      </div>
    </div>

    <div class="research-highlights">
      <h3>Key Findings from Microbiome Research</h3>
      <p><strong>Differences in microbial diversity (alpha and beta) between MDD and HC:</strong> Some diversity measures were altered in patients, and the microbiome composition of patients was more distant/different from that of healthy controls.</p>
      <p><strong>Distinct taxonomic signatures:</strong> There are bacterial genera/families that are elevated in patients and others in healthy controls—identified by LDA (LEfSe), providing clues to microbes that may be associated with disease or health status.</p>
      <p><strong>Microbiome and metabolome/biomarker associations:</strong> Strong associations between specific bacteria and levels of short-chain fatty acids or inflammatory markers—opening up interpretive pathways for the mechanisms of the gut-brain axis.</p>
      <p><strong>Intra-patient heterogeneity:</strong> Not all MDD samples are the same; There are sub-patterns or subgroups (heterogeneity) that may explain variations in response to treatment or severity of symptoms.</p>
    </div>

    <div class="author">Research compiled by: NeuroScence Team</div>
  </div>

  <script>
    const images = document.querySelectorAll('.image-container');
    
    const observer = new IntersectionObserver((entries) => {
      entries.forEach(entry => {
        if (entry.isIntersecting) {
          entry.target.classList.add('visible');
          observer.unobserve(entry.target);
        }
      });
    }, {
      threshold: 0.1,
      rootMargin: '0px 0px -100px 0px'
    });

    images.forEach(img => observer.observe(img));
  </script>
</body>
</html>